Metraipolis › archive › dc_284500a93c26

Emerging and Newly Approved Therapies for Antihistamine-Refractory Chronic Spontaneous Urticaria: A Narrative Review — Europe PMC PMID:42645084

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42645084
DOI: 10.3390/diseases14080276
License (as archived): solo-consultazione
Archived: 2026-10-17T06:51:23.389Z
SHA-256 of the archived text: 0374bfe1d20d7a85594aa2b2a5404a6883b823a2365bb87a995b3e7463b45fc6
Stable URL of this page: https://metraipolis.com/documento/dc_284500a93c26

How to cite

Emerging and Newly Approved Therapies for Antihistamine-Refractory Chronic Spontaneous Urticaria: A Narrative Review — Europe PMC PMID:42645084 — Europe PMC (en), https://europepmc.org/article/MED/42645084 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_284500a93c26 (Metraipolis archive dc_284500a93c26, sha256 0374bfe1d20d7a85594aa2b2a5404a6883b823a2365bb87a995b3e7463b45fc6)

BibTeX

@misc{dc284500a93c26,
  title = {Emerging and Newly Approved Therapies for Antihistamine-Refractory Chronic Spontaneous Urticaria: A Narrative Review — Europe PMC PMID:42645084},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42645084},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_284500a93c26; sha256 0374bfe1d20d7a85594aa2b2a5404a6883b823a2365bb87a995b3e7463b45fc6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42645084. Agents can read the archived copy with the MCP tool read_document.